Cluvot

Cluvot is a pharmaceutical product containing Human Coagulation Factor XIII, used to support blood clotting. This intravenous medication is essential for managing certain bleeding disorders.

Cluvot is primarily used to treat bleeding disorders by aiding in blood clotting. It is often administered to patients with congenital Factor XIII deficiency, a condition that impairs the blood's ability to clot properly. This medication helps to prevent excessive bleeding and supports wound healing.

Cluvot works by enhancing the blood's clotting ability, which can help reduce bleeding episodes. Patients may experience improved wound healing and fewer complications related to bleeding disorders. Common effects include localized reactions at the injection site, such as redness or swelling.

Cluvot should be administered under medical supervision to ensure proper dosage and monitoring. Patients with a history of allergic reactions to blood products should use this medication with caution. It is important to follow storage guidelines to maintain the efficacy of the product.

Cluvot may interact with other medications that affect blood clotting. Patients should inform their healthcare provider about all medications they are taking, including over-the-counter drugs and supplements. Alcohol consumption should be moderated, as it can affect the body's clotting mechanisms.